An academic article from Clinical Infectious Illnesses claims that depression impacts the defense mechanisms by diminishing the varicella zoster virus-cell mediated immunity (VZV-CMI) reaction to a zoster vaccine. This could result in a greater risk and harshness of herpes zoster (HZ). Management of depression through mao inhibitors can normalize the reactions. Therefore without treatment depression boosts the severity and chance of HZ and reduces zoster vaccine effectiveness.
Strategy to herpes zoster ophthalmicus is comparable to standard strategy to herpes zoster at other sites. A current trial evaluating aciclovir using its prodrug, valaciclovir, shown similar efficacies in dealing with this type from the disease. The functional benefit of valciclovir over aciclovir is its dosing of just 3 occasions/day (in comparison with aciclovir’s 5 occasions/day dosing), that could make it simpler for patients and improve adherence with therapy.
“Evaluation of Varicella-Zoster Immune Globulin: Protection of Immunosuppressed Children after Household Contact with Varicella” Journal of Infectious Illnesses. Oxford Journals, Jul 198Web. 20 Marly 201
